Drugs / CHONDRON
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02537067 | Jan 2010 → May 2015 | articular cartilage disorder, joint laxity, familial, osteoarthritis | Cellontech Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHONDRON | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02537067 ↗ |
| Modality | Cell therapy | “CHONDRON (Autologous cultured Chondrocyte) by transplant” NCT02537067 ↗ |
| Route | Other | “CHONDRON (Autologous cultured Chondrocyte) by transplant” NCT02537067 ↗ |